Company: OSRH
Filing Date: 2025-01-31
Form Type: 424B3
Source: 0001213900-25-008874
Chunk: 608

Company: OSR Holdings, Inc.
Filing Date: 2025-01-31
Form: 424B3
Chunk 608
---
 its additional shares of common stock upon consummation of an initial business combination. The shares issuable upon exchange of the rights will be freely tradable (except to the extent held by affiliates of the Company). If the Company enters into a definitive agreement for a business combination in which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same per share consideration the holders of the common stock will receive in the transaction on an as -convertedinto common stock basis. F-46

BELLEVUE LIFE SCIENCES ACQUISITION CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 NOTE 8 — FAIR VALUE MEASUREMENTS The following table presents information about the Company’s assets that are measured at fair value on December31, 2023, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

|                                   |     |   | December 31, 
         2023 |     |   |     Quoted 
  Prices In 
     Active 
    Markets 
  (Level 1) |     |   | Significant 
 Other       
 Observable  
 Inputs      
 (Level 2)   |     |   | Significant  
 Other        
 Unobservable 
 Inputs       
 (Level 3)    |
|:----------------------------------|:----|:--|-------------:|:----|:--|-----------:|:----|:--|:------------|:----|:--|:-------------|
| Assets:                           |     |   |              |     |   |            |     |   |             |     |   |              |
| Investments held in Trust Account |     | $ |   36,605,106 |     | $ | 36,605,106 |     | $ | —           |     | $ | —            |

There were no transfers between Levels1, 2 and 3 during the year ended December31, 2023. NOTE 9 — SUBSEQUENT EVENTS The Company evaluated subsequent events to determine if events or transactions occurred after the balance sheet date up to the date the financial statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements, other than the following: •On February9, 2024, the Company issued an unsecured promissory note (the “JCW Promissory Note”) in the principal amount of $75,000 to Jun Ch